Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesSleep Medicineuniverahealthcare CPAP/APAP Coverage Update | Open…
    Ask Trek AI about this page
    CurrentuniverahealthcarePolicy 1.01.06

    Continuous Positive Airway Pressure (CPAP) and Auto-Adjusting Positive Airway Pressure (APAP) Devices

    Customize your policy alerts

    Sign up for univerahealthcare Policy 1.01.06 alerts

    Get alerted when Policy 1.01.06 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity criteria and coverage rules for Continuous Positive Airway Pressure (CPAP) and Auto-Adjusting Positive Airway Pressure (APAP) devices for adults and children with obstructive sleep apnea, including initial 90-day trials and continuation requirements.

    Policy Summary
    Payeruniverahealthcare
    PolicyContinuous Positive Airway Pressure (CPAP) and Auto-Adjusting Positive Airway Pressure (APAP) Devices
    Policy CodePolicy 1.01.06
    Change TypeCriteria movedthreshold addededitorial revisions
    Effective DateOct 15, 2026
    Last ReviewJun 18, 2026
    Next Review DateJun 1, 2027
    Key ActionFor continuation beyond the 90-day trial, document improved AHI/symptoms and device compliance of ≥70% of nights for ≥4 hours/night during a consecutive 30-day period.
    SourceLink
    POLICY UPDATE CHANGES

    BiPAP and non-invasive ventilator criteria and associated codes were removed and placed into the new medical policy #1.01.57 for Home Non-Invasive Positive Pressure Ventilation (NIPPV).

    Policy edit with duplicative criteria removed while policy intent remained unchanged.

    Added medically necessary criteria for initial CPAP device requests when the individual has documented AHI or RDI greater than a threshold (text truncated in this excerpt).

    Summary of changes tracking was implemented.

    90-dayinitial trial duration
    70%/≥4 hrs

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    compliance threshold
    AHI ≥15adult OSA threshold
    AHI >5–<15adult mild OSA range
    3–20 cm H2OCPAP pressure range
    1.01.57related new policy

    Coverage Criteria for CPAP / APAP Devices

    Adult indications (Initial Therapy)

    Covered when ANY one of the following is met:

    Adult OSA — mild with symptoms: Polysomnography (PSG) or home sleep testing (HST) documents an AHI or RDI >5 and <15 respiratory events per hour AND the patient has symptoms of OSA (e.g., excessive daytime sleepiness, impaired cognition, insomnia).AHI/RDI >5 and <15

    chunk 4

    Adult OSA — mild with cardiovascular disease: PSG or HST documents an AHI or RDI >5 and <15 respiratory events per hour AND documented cardiovascular disease (including hypertension, ischemic heart disease, or history of stroke).AHI/RDI >5 and <15

    chunk 5

    Adult OSA — moderate to severe: PSG or HST documents an AHI or RDI ≥15 respiratory events per hour.AHI/RDI ≥15

    chunk 6

    Pediatric indications (Initial Therapy)

    Covered when ANY one of the following pediatric-specific conditions is met (90-day continuation review not required for pediatric members):

    Post-adenotonsillectomy failure: Child <18 years with OSA after adenotonsillectomy that failed to relieve OSA symptoms.clinical

    chunk 7

    Contraindication to surgery: Child <18 years with OSA who has a contraindication to surgical intervention.clinical

    chunk 8

    Nonsurgical preference: Child <18 years for whom a nonsurgical approach is strongly preferred.clinical

    chunk 9

    Continuation of coverage after 90-day trial

    Continuation is covered when BOTH of the following are demonstrated:

    Improvement and compliance: 1) Improved AHI and symptom resolution during the 90-day trial; AND 2) Demonstrated compliance with device use (defined as using the device ≥70% of nights for ≥4 hours per night during a consecutive 30-day period).AHI improvement; 70% of nights for ≥4 hours

    chunks 16,17

    Repair of medically necessary CPAP (out of warranty)

    Repair is considered medically appropriate when ALL of the following are met:

    Repair criteria: Physician documentation includes all of the following: date of DME initiation; manufacturer warranty information (if applicable); attestation that the patient has been compliant with the DME and will continue to benefit; statement that the DME is no longer functioning adequately and that inadequate function interferes with activities of daily living; and documentation that repair is expected to restore full function as defined by the manufacturer.

    chunks 20-24

    Replacement of medically necessary CPAP (out of warranty)

    Replacement is considered medically appropriate when ALL of the following are met:

    Replacement criteria: Proof of compliance with positive pressure therapy (see continuation criteria after 90-day trial) AND either: the DME is no longer functioning and has been determined nonrepairable, or the cost of repair exceeds the replacement cost and improvement is expected with a replacement unit. Note: replacement of a properly functioning CPAP, components, or accessories (including for advanced technology or aesthetics) is not medically necessary.

    chunks 27-30

    Device selection and alternatives

    Covered when appropriate for management of OSA and intolerance to first-line therapy:

    Device selection and alternatives: Fixed-level CPAP is the primary, guideline-supported therapy for adults with documented OSA. APAP and CPAP with expiratory relief are covered alternatives for patients who cannot tolerate fixed-level CPAP or high constant pressures.

    chunks 36,49,54

    Short-term replacement/monitoring billing

    Operational coverage rules:

    Temporary rental when out of warranty: A one-month rental is allowed when a CPAP device is malfunctioning and out of warranty (and not related to a manufacturer recall) while the device is being repaired.1 month

    chunk 38

    Guideline-based coverage criteria

    Covered when following guideline-based conditions are met or when device is indicated per referenced clinical guidance

    Guideline-recommended device choices: Offer fixed-level CPAP for mild OSA when symptoms affect quality of life and lifestyle changes are unsuccessful; APAP is an alternative for those unable to tolerate CPAP; a customized mandibular advancement device may be used if PAP is refused or not tolerated.

    chunks 54,55

    Moderate to severe OSA guidance: CPAP is recommended for moderate to severe OSA; APAP may be offered when CPAP is not tolerated.

    chunk 55

    Pediatric OSAS guidance: Polysomnography is recommended for children with snoring and symptoms; adenotonsillectomy is first-line for adenotonsillar hypertrophy, and CPAP is recommended if surgery is not performed or OSAS persists postoperatively.

    chunks 56,58

    Initial Therapy

    Covered when ALL of the following are met (excerpted references):

    Initial CPAP requirement: Individual has documented AHI or RDI greater than the policy threshold (exact numeric threshold referenced in policy threshold entries).see threshold entry

    chunk 73

    Requests for continuous positive airway pressure (CPAP) that are intended solely to treat snoring without documented obstructive sleep apnea (OSA) are considered not medically necessary. Coverage requires objective evidence of OSA (see policy thresholds for required AHI/RDI documentation).

    Repair or replacement claims for CPAP equipment that was damaged or lost due to patient neglect, theft, or abuse are ineligible for coverage. Likewise, if another available coverage source exists (for example, homeowners, rental, auto, or liability insurance), repair or replacement should be pursued through that source and is not covered under this policy.

    Replacement of a properly functioning CPAP device, its components, or accessories is not medically necessary. This exclusion includes replacements sought for reasons of upgraded technology or improved aesthetics rather than clinical need; routine or elective swaps of functioning equipment will not be covered.

    Accessories or components that the peer‑reviewed literature has deemed not medically necessary or investigational are excluded from coverage. The Health Plan will apply the same determinations when assessing coverage for CPAP-related accessories and components.

    Devices marketed to clean or sanitize CPAP equipment (for example, SoClean and similar products) are classified as convenience items and are ineligible for coverage. Claims for such cleaning/sanitizing devices will be denied under this policy.

    Coverage under this medical policy is dependent on the member's product. If a given product does not cover a service, the medical policy criteria do not apply and the service is considered excluded for that product. Providers should verify contract-specific coverage before submitting requests.

    Criteria and billing codes for bilevel positive airway pressure (BiPAP) and other non‑invasive ventilators have been removed from this CPAP/APAP policy and relocated to Medical Policy 1.01.57 (Home Non‑Invasive Positive Pressure Ventilation). Requests for these devices should be evaluated under that policy.

    Use of CPAP for isolated snoring in the absence of documented obstructive sleep apnea is explicitly listed as not medically necessary. Providers should document diagnostic testing demonstrating OSA when seeking coverage for positive airway pressure therapy.

    CPAP is considered not medically necessary for treatment of snoring when there is no accompanying diagnosis of obstructive sleep apnea (OSA). Coverage requires objective sleep testing (PSG or HST) demonstrating OSA per policy thresholds.

    Procedure and supply codes in the policy may be annotated as Experimental/Investigational (E/I) or Not Medically Necessary (NMN) where applicable. Specific code‑level determinations are provided in the policy's coding sections and should be referenced when submitting claims.

    Any request for BiPAP or other non‑invasive ventilator devices submitted under this CPAP/APAP policy may be considered not applicable and should instead be assessed under Medical Policy 1.01.57. Providers should redirect prior authorization requests and coding inquiries for these devices to that related policy.

    Coding and Billing Codes

    No explicit codes listed in this sectionmixed
    No codes listed
    Monitoring device HCPCSHCPCS
    A9279Monitoring feature/device, stand-alone or integrated, any type, including all accessories, components, and electronics, not otherwise classified
    Covered CPT CodesCPTCovered
    94660Continuous positive airway pressure ventilation (CPAP), initiation and management
    HCPCS CodesHCPCSCovered
    A7027-A7039Accessories/supplies, code range for positive pressure airway devices (code range)
    A7044-A7046Accessories/supplies, code range for positive pressure airway devices (code range)
    A9279Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified
    E0561Humidifier, nonheated, used with positive airway pressure device
    E0562Humidifier, heated, used with positive airway pressure device
    E0601Continuous airway pressure (CPAP) device
    ICD-10 Codes (listed)ICD-10
    E66.2Morbid (severe) obesity with alveolar hypoventilation
    G47.00Insomnia, unspecified
    G47.10Hypersomnia, unspecified
    G47.20Circadian rhythm sleep disorder, unspecified type
    G47.8Other sleep disorders
    G47.9Sleep disorder, unspecified
    I50.9Heart failure, unspecified
    J39.8Other specified diseases of upper respiratory tract
    J44.1Chronic obstructive pulmonary disease with (acute) exacerbation
    J44.9Chronic obstructive pulmonary disease, unspecified
    1–10 of 17
    1/2
    Codes moved to policy 1.01.57mixed
    No codes listed
    inv-27: Key numeric thresholds — AHI/RDI and other numeric thresholds
    Adult mild OSAAHI or RDI >5 and <15 events/hour (with symptoms or cardiovascular disease)
    Adult moderate–severe OSAAHI or RDI ≥15 events/hour
    Pediatric diagnostic thresholdPediatric AHI or RDI ≥5 events/hour (with symptoms)
    Pediatric hypercarbia — absoluteEnd-tidal CO2 >53 mm Hg
    Pediatric hypercarbia — time-basedEnd-tidal CO2 >50 mm Hg for 10–24% of sleep time
    Compliance metric for continuation

    Provider Requirements, Documentation, and Billing Guidance

    Prior Authorization

    90-day trial; continuation requires improvement + compliance

    Initial therapy is a 90-day trial. Continuation beyond the 90-day trial requires both documented improvement in AHI and symptoms during the trial and demonstrated compliance (e.g., device use ≥70% of nights for ≥4 hours per night during a consecutive 30-day period).

    Documentation Required

    Document device compliance for replacement/continuation

    Proof of compliance with positive pressure device use must be documented when seeking replacement or continuation after the initial trial, referencing the same compliance definition used for continuation (70% of nights for ≥4 hours/night over 30 consecutive days).

    Background and Clinical Context

    Obstructive sleep apnea (OSA) is diagnosed by polysomnography (PSG) or home sleep testing (HST) using the apnea–hypopnea index (AHI) or respiratory disturbance index (RDI). These indices are used to determine medical necessity for CPAP/APAP initiation and continuation; documentation of AHI/RDI and clinical symptoms or comorbid conditions is required per the coverage criteria.

    Definitions and Key Terms

    inv-55: AHI/RDI thresholds — adult thresholds and qualification statements.
    Adult mild OSA qualificationAHI or RDI >5 and <15 events/hour with associated symptoms or cardiovascular disease qualifies for CPAP/APAP
    Adult moderate–severe qualificationAHI or RDI ≥15 events/hour qualifies for CPAP/APAP
    Pediatric qualifying criteriaChildren with PSG AHI or RDI ≥5 with symptoms, or normal AHI with symptoms plus hypercarbia meet pediatric indications
    inv-56: Pediatric hypercarbia thresholds — end-tidal CO2 cutoffs.
    Absolute hypercarbia cutoff (pediatrics)End-tidal CO2 >53 mm Hg
    Time-based hypercarbia criterion (pediatrics)End-tidal CO2 >50 mm Hg for 10–24% of sleep time

    Policy Revision and Approval History

    2026-06-18Committee approvalLatest

    Policy committee approved the policy on 06/18/26 (listed as the most recent committee approval).

    2025-07-17Committee approval

    Policy committee approved the policy on 07/17/25 (prior committee approval entry).

    2025-01-01Off-cycle review/criteria added
    Policy Summary
    Payeruniverahealthcare
    PolicyContinuous Positive Airway Pressure (CPAP) and Auto-Adjusting Positive Airway Pressure (APAP) Devices
    Policy CodePolicy 1.01.06
    Change TypeCriteria movedthreshold addededitorial revisions
    Effective DateOct 15, 2026
    Last ReviewJun 18, 2026
    Next Review DateJun 1, 2027
    Key ActionFor continuation beyond the 90-day trial, document improved AHI/symptoms and device compliance of ≥70% of nights for ≥4 hours/night during a consecutive 30-day period.
    SourceLink
    On This Page
    Coverage Criteria for CPAP / APAP DevicesCoding and Billing CodesProvider Requirements, Documentation, and Billing GuidanceBackground and Clinical ContextDefinitions and Key TermsPolicy Revision and Approval History
    Pediatric PSG AHI ≥5 with symptoms: PSG results documenting an AHI or RDI ≥5 and the child exhibits OSA symptoms.AHI/RDI ≥5

    chunk 10

    Pediatric symptoms with hypercarbia: PSG shows AHI/RDI within normal ranges but the child exhibits OSA symptoms AND either end-tidal CO2 >53 mm Hg OR end-tidal CO2 >50 mmHg for 10–24% of sleep time.end-tidal CO2 criteria

    chunks 11,13,14

    Use device ≥70% of nights for ≥4 hours/night over a consecutive 30-day period
    inv-28: Initial trial period — 90-day
    Initial trial duration90-day trial period for initial CPAP/APAP therapy
    Re-evaluation after failureClinical re-evaluation by treating physician required if criteria not met after initial 90-day trial
    Pediatric continuation note90-day continuation review is not required for pediatric members
    inv-29: Adherence threshold — ≥4 hours per day
    Adherence definition for continuationUse device ≥70% of nights for ≥4 hours/night during a consecutive 30-day period
    Adherence linked to outcomesOn-treatment analyses show CPAP adherence ≥4 hours/day associated with reduced MACCEs recurrence
    Documentation requirementProof of device compliance must be documented for replacement and continuation requests
    inv-30: CPAP pressure range — 3 to 20 cm water
    Usual CPAP pressure rangeTherapeutic pressure range typically determined individually: 3 to 20 cm water
    Pressure selection basisPressure chosen to raise intraluminal upper airway pressure above critical transmural pressure for airway patency
    Device technologies that affect pressure comfortCPAP with expiratory relief reduces expiratory pressure proportional to expiratory flow to improve comfort
    inv-31: AHI/RDI documentation note (partial value present in history)
    AHI/RDI documentation requiredInitial CPAP device requests must include documented AHI or RDI greater than the policy threshold (documented in sleep study reports)
    Partial values in historyPolicy history notes an added criterion for initial CPAP when documented AHI/RDI is greater than a threshold, but the exact numeric threshold text is truncated in excerpt
    Acceptable testsPolysomnography (PSG) or home sleep testing (HST) results may be used to document AHI/RDI
    inv-32: AHI/RDI threshold for initial CPAP (exact numeric threshold not present in provided chunks)
    AHI/RDI threshold — policy excerptPolicy states initial CPAP requests require documented AHI or RDI greater than a threshold; exact numeric threshold not included in provided excerpt
    Operational noteCommittee change log indicates an off-cycle addition of a threshold criterion but the numeric value is truncated in the document excerpt
    Action for providersRefer to full policy record or prior authorization guidance for the precise numeric threshold when processing initial CPAP requests
    Billing Rule

    Monitoring (A9279) inclusive; one-month rental if out-of-warranty

    The monitoring feature/device (HCPCS A9279) is considered inclusive to the positive airway pressure device and is not separately reimbursable; when a CPAP malfunctions and is out of warranty (not due to manufacturer recall), coverage is allowed for a one-month rental while the device is repaired.

    • HCPCS A9279 is inclusive to the PAP device and not separately billable.
    • One-month rental allowed for malfunctioning, out-of-warranty CPAP during repair (recall exclusions apply).
    Prior Authorization

    Prior authorization required for PAP devices and supplies

    Prior authorization is required for CPAP/APAP devices and associated supplies and codes listed in the policy (including CPT 94660 and HCPCS E0601, A70xx ranges, A9279, E0561/E0562).

    • Examples: CPT 94660; HCPCS E0601, A7027–A7039, A7044–A7046, A9279, E0561, E0562.
    Prior Authorization

    PA for initial CPAP requests: include sleep study showing AHI/RDI above threshold

    Initial CPAP requests require prior authorization and must include documentation of a sleep study (PSG or HST) showing a documented AHI or RDI greater than the policy threshold, plus relevant clinical information as described in the policy.

    Step Therapy

    Pediatric pathway: CPAP/APAP when surgery fails, contraindicated, or not preferred

    For children <18 years, CPAP/APAP is appropriate when adenotonsillectomy has failed to relieve OSA symptoms, surgery is contraindicated, or a nonsurgical approach is strongly preferred; note that a 90-day continuation review is not required for pediatric members.

    • Failure of adenotonsillectomy to relieve symptoms.
    • Contraindication to surgical intervention.
    • Strong preference for nonsurgical approach.
    Step Therapy

    If intolerant of fixed CPAP pressure, try expiratory relief CPAP or APAP

    If a patient cannot tolerate constant high CPAP pressure, consider CPAP with expiratory relief or APAP as alternate options before discontinuing positive pressure therapy.

    • CPAP with expiratory relief (e.g., C-Flex) or APAP may improve tolerance.
    Step Therapy

    Use APAP or CPAP with expiratory relief if fixed-level CPAP not tolerated

    APAP or CPAP with expiratory relief may be used as alternatives when a patient does not tolerate standard fixed-level CPAP.

    Note

    Offer fixed-level CPAP first for symptomatic mild OSA; APAP if intolerant

    Guideline-preferred initial therapy: offer fixed-level CPAP for individuals with mild OSA whose symptoms affect quality of life and who have not improved with lifestyle changes; APAP may be offered as an alternative if CPAP is not tolerated.

    • Fixed-level CPAP recommended for symptomatic mild OSA after unsuccessful lifestyle measures.
    • APAP as alternative when CPAP intolerance occurs.
    Documentation Required

    Include sleep study results and symptom/comorbidity documentation

    Documentation must include polysomnography (PSG) or home sleep testing (HST) results showing the AHI or RDI used to establish medical appropriateness, along with related symptoms or comorbid conditions.

    • Include PSG/HST report with AHI or RDI values.
    • Document associated symptoms (e.g., daytime sleepiness) or comorbid cardiovascular disease when applicable.
    Documentation Required

    Include pediatric end-tidal CO2 or sleep study data when applicable

    For pediatric members when hypercarbia is relevant, include end-tidal CO2 measurements or sleep study documentation (e.g., end-tidal CO2 >53 mm Hg or >50 mm Hg for 10–24% of sleep time) as applicable to support medical necessity.

    Documentation Required

    Documentation required for repair: DME date, warranty, compliance, function, repair expectation

    For repair authorization, physician documentation must include the date of DME initiation, manufacturer warranty information if applicable, attestation that the patient has been compliant and continues to benefit, description that the DME is no longer functioning adequately and interferes with activities of daily living, and that repair is expected to restore full function per manufacturer definition.

    Billing Rule

    Monitoring inclusive; short-term rental allowed if device out of warranty

    Monitoring features/devices (HCPCS A9279) are considered inclusive to the PAP device and not separately billable; when a CPAP malfunctions and is out of warranty (not due to manufacturer recall), coverage is allowed for a one-month rental while the device is repaired.

    Documentation Required

    Provide PAP education, mask fitting, demonstration before titration

    Before titration, candidates should receive PAP education, hands-on demonstration, careful mask fitting, and acclimatization as part of pre-titration preparation per AASM guidance.

    Prior Authorization

    Include documented AHI or RDI > policy threshold for initial CPAP requests

    Initial CPAP device requests must include documentation of a documented AHI or RDI greater than the policy threshold; ensure the sleep study report is attached to the request (exact numeric threshold referenced in policy materials).

    Denial Risk

    CPAP for isolated snoring may be denied (not medically necessary)

    Requests for CPAP solely to treat snoring without documented obstructive sleep apnea are considered not medically necessary and may be denied.

    Denial Risk

    Damage/loss exclusions: neglect, theft, abuse, or alternate coverage

    Repair or replacement claims are ineligible if the equipment was damaged or lost due to patient neglect, theft, abuse, or when another available coverage source (e.g., homeowners or auto insurance) exists.

    Denial Risk

    Cleaning/sanitizing devices (e.g., SoClean) not covered

    Devices used to clean or sanitize CPAP devices (for example, SoClean) are considered convenience items and are ineligible for coverage; claims for such devices may be denied.

    Note

    Policy applicability is contract dependent — check member product coverage

    Coverage and applicability of this policy are contract dependent; if a product does not cover a service, medical policy criteria do not apply which may lead to denial based on the member’s product.

    Note

    BiPAP/NIPPV device requests moved to policy 1.01.57

    Requests for BiPAP and other non-invasive ventilators and associated codes have been moved to policy 1.01.57; such requests may be redirected or denied under this policy and should be submitted under policy 1.01.57.

    Clinical contextObstructive hypoventilation in children may present with normal AHI but episodes of hypercarbia indicated by elevated end-tidal CO2
    inv-57: CPAP for snoring — not medically necessary when used solely for snoring.
    Snoring without OSACPAP is not medically necessary when prescribed solely for snoring without accompanying obstructive sleep apnea
    Denial riskRequests for CPAP for isolated snoring may be denied as not medically necessary
    Documentation implicationProviders should document objective sleep testing demonstrating OSA before prescribing CPAP for snoring
    inv-58: Adjuncts — Supplemental oxygen or humidification definitions.
    Supplemental oxygen as adjunctSupplemental oxygen can be added to positive pressure devices to increase oxygen saturation
    Humidification as adjunctHumidification (heated or non-heated) may be added to reduce vasomotor rhinitis and improve comfort
    Billing/coverage noteAdjuncts are considered additions to PAP devices; humidifiers have HCPCS codes (E0561, E0562) listed in policy code sections
    inv-59: Obstructive Sleep Apnea (OSA) — definition entry.
    DefinitionObstructive sleep apnea (OSA) is a sleep-related breathing disorder caused by upper-airway obstruction with recurrent episodes often lasting >10 seconds in adults
    DiagnosisDiagnosis requires polysomnography or home sleep testing with evidence of clinical impairment
    Clinical consequencesUntreated OSA increases risk of hypertension, heart failure, atrial fibrillation, and other comorbidities
    inv-60: Central Sleep Apnea — definition entry.
    DefinitionCentral sleep apnea is cessation of airflow for at least 10 seconds with no respiratory effort
    EtiologyMay be due to neurologic causes or have an obstructive component
    Prevalence noteApproximately 4% of individuals undergoing PSG are diagnosed with central sleep apnea
    inv-61: APAP — device definition.
    DefinitionAPAP (auto- or self-titrating positive airway pressure) uses algorithms and pressure transducers to adjust pressure in response to detected events or airflow patterns
    SynonymsAlso referred to as demand positive airway pressure (DPAP)
    Use caseOffered as an alternative when fixed-level CPAP is not tolerated
    inv-62: CPAP with expiratory relief — definition entry.
    DefinitionCPAP with expiratory relief reduces expiratory pressure proportional to expiratory flow to improve comfort (e.g., C-Flex)
    ApplicabilityTechnology can be applied to CPAP, BPAP, and APAP devices to improve tolerability
    Expected benefitMay increase compliance in patients who find exhalation against constant pressure uncomfortable
    inv-63: APAP — alternative note.
    APAP as alternativeAPAP may be used as an alternative to fixed-level CPAP when CPAP is not tolerated
    Guideline supportNICE and professional guidance support APAP as an alternative in intolerance to CPAP
    Operational implicationAPAP devices contain algorithms and monitoring features that can support titration and adherence tracking
    inv-64: Bilevel NIV — definition for respiratory failure/COPD context.
    Definition and contextBilevel noninvasive ventilation (NIV) is recommended for acute respiratory failure with acute or acute-on-chronic respiratory acidosis (pH <7.35) due to COPD exacerbation
    Indication distinctionBilevel NIV is outside scope of this CPAP/APAP policy and has been reallocated to policy 1.01.57 for NIPPV
    Treatment noteBilevel NIV associated with reduced mortality and hospital admissions in COPD in supportive literature
    inv-65: Documented AHI/RDI used to determine medical necessity for CPAP initiation.
    Documented AHI/RDI requirementDocumented AHI or RDI from PSG or HST is used to determine medical necessity for CPAP initiation
    Acceptable documentationPSG or home sleep testing results should be included in initial device requests
    Policy history noteAn off-cycle change added a criterion requiring documented AHI/RDI greater than a threshold; exact numeric value is truncated in excerpt — see full policy for number

    Off-cycle review added medically necessary criteria for initial CPAP requests when the individual has a documented AHI or RDI greater than a specified threshold.

    2025-01-23Committee approval

    Policy committee approved the policy on 01/23/25 (committee approval entry).

    2024-01-18Committee approval

    Policy committee approved the policy on 01/18/24 (committee approval entry).

    2023-01-19Committee approval

    Policy committee approved the policy on 01/19/23 (committee approval entry).

    2022-03-24Committee approval

    Policy committee approved the policy on 03/24/22 (committee approval entry).

    2021-07-15Committee approval

    Policy committee approved the policy on 07/15/21 (committee approval entry).

    2020-06-25Committee approval

    Policy committee approved the policy on 06/25/20 (committee approval entry).

    2019-06-27Committee approval

    Policy committee approved the policy on 06/27/19 (committee approval entry).

    2018-04-26Committee approval

    Policy committee approved the policy on 04/26/18 (committee approval entry).

    2017-04-27Committee approval

    Policy committee approved the policy on 04/27/17 (committee approval entry).

    2017-08-25Committee approval

    Policy committee approved the policy on 08/25/17 (committee approval entry).

    2013-04-25_to_2016-04-28Committee approval

    Committee approval period listed from 04/25/13 through 04/28/16 (grouped approval entries in source).

    2012-04-26Committee approval

    Policy committee approved the policy on 04/26/12 (committee approval entry).

    2011-04-28Committee approval

    Policy committee approved the policy on 04/28/11 (committee approval entry).

    2009-02-26Committee approval

    Policy committee approved the policy on 02/26/09 (committee approval entry).

    2008-06-26Committee approval

    Policy committee approved the policy on 06/26/08 (committee approval entry).

    2007-04-26Committee approval

    Policy committee approved the policy on 04/26/07 (committee approval entry).

    2006-03-16Committee approval

    Policy committee approved the policy on 03/16/06 (committee approval entry).

    2005-04-21Committee approval

    Policy committee approved the policy on 04/21/05 (committee approval entry).

    2005-01-20Committee approval

    Policy committee approved the policy on 01/20/05 (committee approval entry).

    2003-12-18Committee approval

    Policy committee approved the policy on 12/18/03 (committee approval entry).

    2003-02-20Committee approval

    Policy committee approved the policy on 02/20/03 (committee approval entry).

    2002-01-17Committee approval

    Policy committee approved the policy on 01/17/02 (committee approval entry).

    2001-10-18Committee approval

    Policy committee approved the policy on 10/18/01 (committee approval entry).